National Cancer Institute; Amended Notice of Meeting, 60539 [05-20742]

Download as PDF 60539 Federal Register / Vol. 70, No. 200 / Tuesday, October 18, 2005 / Notices EXHIBIT 1—Continued Number of respondents Type of respondents * Dietary Recall 3 ........................................................................................ Mail Survey ............................................................................................... Pilot Study 2: Mail Survey ............................................................................................... Main Implementation 5 A Day Customized Survey .................................................................... Total ................................................................................................... Frequency of response Average burden hours Annual hour burden 290 200 1 1 .50 .42 145 84 200 2 .42 168 4,000 1 .42 1,680 5,875 ........................ ........................ 2,467.90 *All respondents are consumer panel members. Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proposed performance of the functions of the agency, including whether the information shall have practical utility; (2) the accuracy of the estimate of the burden of the proposed collection of information including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, New Executive Office Building, Room 10235, Washington, DC 20503, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Amy Lazarus Yaroch, Ph.D., Project Officer, National Cancer Institute, NIH, EPN 4074, 6130 Executive Boulevard MSC 7335, Bethesda, Maryland 20892–7335, or call non-toll-free number 301–402– 8425, or FAX your request to 301–480– 2087, or E-mail your request, including your address, to yarocha@mail.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of this notice. VerDate Aug<31>2005 17:22 Oct 17, 2005 Jkt 208001 Dated: October 5, 2005. Rachelle Ragland-Greene, NCI OMB Clearance Liaison, National Institutes of Health. [FR Doc. 05–20756 Filed 10–17–05; 8:45 am] Dated: October 4, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–20748 Filed 10–17–05; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Office of Biotechnology Activities, Office of the Director; Notice of Meeting National Cancer Institute; Amended Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a special meeting of the National Science Advisory Board for Biosecurity (NSABB) that was held by teleconference on September 29, 2005. The Secretary determined that advance notice was not possible, and that the meeting had to be closed to the public in accordance with the provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. Under authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established NSABB to provide advice, guidance and leadership regarding Federal oversight of dual-use research, defined as biological research with legitimate scientific purposes that could be misused to pose a biological threat to public health and/or national security. Name of Committee: National Science Advisory Board for Biosecurity. Date: September 29, 2005. Closed: 10 a.m. to 12 p.m. Agenda: To review confidential information. Place: 6705 Rockledge Drive, Bethesda, Maryland, (Telephone Conference Call). Contact Person: Allison Chamberlain, NSABB Program Assistant, 6705 Rockledge Drive, Bethesda, Maryland 20892, (301) 496– 9838. PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Notice is hereby given of a change in the meeting of the President’s Cancer Panel, October 24, 2005, 8 a.m. to October 24, 2005, 5 p.m., Hotel Washington, Pennsylvania Ave at 15th Street, NW., Washington, DC, 20004 which was published in the Federal Register on September 27, 2005, 70 FR 56477. This meeting is amended to change the end time of the open session from 5 p.m. to 4 p.m. on October 24, 2005 and the date and time of the closed session from 1 p.m.–4 p.m. on October 25, 2005 to 4:15 p.m.–6:15 p.m. on October 24, 2005. The meeting is partially Closed to the public. Dated: October 5, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–20742 Filed 10–17–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closing Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. E:\FR\FM\18OCN1.SGM 18OCN1

Agencies

[Federal Register Volume 70, Number 200 (Tuesday, October 18, 2005)]
[Notices]
[Page 60539]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-20742]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the 
President's Cancer Panel, October 24, 2005, 8 a.m. to October 24, 2005, 
5 p.m., Hotel Washington, Pennsylvania Ave at 15th Street, NW., 
Washington, DC, 20004 which was published in the Federal Register on 
September 27, 2005, 70 FR 56477.
    This meeting is amended to change the end time of the open session 
from 5 p.m. to 4 p.m. on October 24, 2005 and the date and time of the 
closed session from 1 p.m.-4 p.m. on October 25, 2005 to 4:15 p.m.-6:15 
p.m. on October 24, 2005. The meeting is partially Closed to the 
public.

    Dated: October 5, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-20742 Filed 10-17-05; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.